PMID- 33312726 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220418 IS - 2090-004X (Print) IS - 2090-0058 (Electronic) IS - 2090-004X (Linking) VI - 2020 DP - 2020 TI - The Prevalence and Causes of Visual Impairment in Type 2 Diabetes Mellitus in Northeast China. PG - 5969816 LID - 10.1155/2020/5969816 [doi] LID - 5969816 AB - PURPOSE: To evaluate the prevalence and causes of visual impairment in a group of community people with type 2 diabetes mellitus (T2DM) in Northeast China. METHODS: Population-based cross-sectional survey. Patients diagnosed with T2DM residing in 15 communities in Fushun, Northeast China, were enrolled between July 2012 and May 2013. All participants underwent an extensive and standardized eye examination (visual acuity testing, slit-lamp, and fundus examination). Low vision was defined as presenting VA of better-seeing eye <20/60 and >/=20/400, and blindness was defined as VA <20/400, according to the World Health Organization (WHO) definitions. The primary causes of blindness and low vision were assessed by senior ophthalmologists. RESULTS: Visual acuity measurements were available for 1998 (89.8%) of 2224 subjects in the study. The prevalence of bilateral blindness and low vision defined was 0.90% and 10.81%. Uncorrected refractive error was the first leading cause of low vision (75.0%) and blindness (38.9%). After correcting the refractive error, the first leading cause of low vision was cataract (44.4%), followed by diabetic retinopathy (29.6%) and myopic maculopathy (18.5%), while the first leading cause of blindness was proliferative DR (45.4%), followed by cataract (36.4%) and myopic maculopathy (18.2%). CONCLUSIONS: This study suggested a high prevalence of low vision and blindness in this study cohort. Uncorrected refractive error and cataract remain the leading cause of visual impairment, but the major challenge is the early diagnosis and intervention of diabetic retinopathy to reduce diabetes-related blindness. CI - Copyright (c) 2020 Liang Wen et al. FAU - Wen, Liang AU - Wen L AD - Fushun Eye Hospital, Fushun, Liaoning, China. FAU - Wang, Yu AU - Wang Y AD - Fushun Eye Hospital, Fushun, Liaoning, China. FAU - Lin, Zhong AU - Lin Z AUID- ORCID: 0000-0002-4828-7157 AD - The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China. FAU - Wang, Feng Hua AU - Wang FH AD - Beijing Tongren Eye Center, Capital Medical University, Beijing Ophthalmology & Visual Science Key Lab, Beijing, China. FAU - Ding, Xiao Xia AU - Ding XX AD - Fushun Eye Hospital, Fushun, Liaoning, China. FAU - Li, Dong AU - Li D AD - Fushun Eye Hospital, Fushun, Liaoning, China. FAU - Feng, Kemi AU - Feng K AD - The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China. FAU - Liang, Yuan Bo AU - Liang YB AUID- ORCID: 0000-0001-9685-7356 AD - The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China. FAU - Zhang, Dong Xiao AU - Zhang DX AD - Fushun Eye Hospital, Fushun, Liaoning, China. FAU - Dou, Yu AU - Dou Y AD - Fushun Eye Hospital, Fushun, Liaoning, China. FAU - Zhai, Gang AU - Zhai G AUID- ORCID: 0000-0003-2219-5470 AD - Fushun Eye Hospital, Fushun, Liaoning, China. LA - eng PT - Journal Article DEP - 20201129 PL - United States TA - J Ophthalmol JT - Journal of ophthalmology JID - 101524199 PMC - PMC7719542 COIS- All authors declare that they have no conflicts of interest. EDAT- 2020/12/15 06:00 MHDA- 2020/12/15 06:01 PMCR- 2020/11/29 CRDT- 2020/12/14 10:58 PHST- 2019/12/31 00:00 [received] PHST- 2020/04/01 00:00 [accepted] PHST- 2020/12/14 10:58 [entrez] PHST- 2020/12/15 06:00 [pubmed] PHST- 2020/12/15 06:01 [medline] PHST- 2020/11/29 00:00 [pmc-release] AID - 10.1155/2020/5969816 [doi] PST - epublish SO - J Ophthalmol. 2020 Nov 29;2020:5969816. doi: 10.1155/2020/5969816. eCollection 2020.